EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

sFlt-1/PlGF and beyond: angiolymphatic-associated signatures and emerging biomarkers in placental pathology

Seetu Palo iD, Mishu Mangla iD, Rohini Motwani iD

Vascular Biology · 01.01.2025 · 7 (1)

DOI: 10.1530/vb-25-0009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vascular Biology, online erschienen am 27.11.2025. Verfasst von Seetu Palo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bibinagar, Telangana, India. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The placenta is a highly vascularised organ that depends on tightly regulated angiolymphatic networks to sustain normal fetal growth and maternal adaptation to pregnancy. Disruption of these pathways contributes to major obstetric complications, including preeclampsia, fetal growth restriction, gestational diabetes, and stillbirth. In recent years, advances in molecular pathology and high-throughput technologies have identified a spectrum of angiogenic, lymphangiogenic, and endothelial biomarkers that provide mechanistic insights and hold translational promise. Among these, vascular endothelial growth factors (VEGF-A, VEGF-C, VEGF-D), placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), angiopoietins, podoplanin, and lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) have emerged as key regulators. Differential expression of these markers in placental tissue, maternal circulation, and extracellular vesicles has been correlated with disease severity, placental morphology, and adverse neonatal outcomes. Despite growing evidence, clinical application is limited by methodological heterogeneity, gestational age–specific variability, and incomplete understanding of lymphatic involvement in placental physiology. This review synthesises current knowledge on angiolymphatic biomarkers in the placenta, highlighting their role in vascular development, disease pathogenesis, and potential as diagnostic and prognostic tools. Future research integrating molecular assays, imaging modalities, and systems biology approaches is essential to standardise biomarker panels and translate them into clinically meaningful strategies for maternal–fetal medicine.

Schlagwörter

Stichwörter der Autor:innen

VEGFangiolymphatic networkbiomarkersplacentapodoplaninsFlt-1/PlGF

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bibinagar, Telangana, India.
  • Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences, Bibinagar, Telangana, India.
  • Department of Anatomy, All India Institute of Medical Sciences, Bibinagar, Telangana, India.

ORCID-Profile: Seetu Palo, Mishu Mangla, Rohini Motwani

Zitieren

APA

Palo, S., Mangla, M., & Motwani, R. (2025). sFlt-1/PlGF and beyond: angiolymphatic-associated signatures and emerging biomarkers in placental pathology. Vascular Biology, 7(1). https://doi.org/10.1530/vb-25-0009

Vancouver

Palo S, Mangla M, Motwani R. sFlt-1/PlGF and beyond: angiolymphatic-associated signatures and emerging biomarkers in placental pathology. Vascular Biology. 2025;7(1). doi:10.1530/vb-25-0009

BibTeX
@article{Palo2025,
  author = {Palo, Seetu and Mangla, Mishu and Motwani, Rohini},
  title = {sFlt-1/PlGF and beyond: angiolymphatic-associated signatures and emerging biomarkers in placental pathology},
  journal = {Vascular Biology},
  year = {2025},
  volume = {7},
  number = {1},
  doi = {10.1530/vb-25-0009}
}
Kostenlos starten →